title: [A study of non-muscle-invasive bladder cancer therapy : Treatment of high-grade non-muscle-invasive urothelial carcinoma of the bladder with the standard number and dosage of intravesical BCG instillations versus a reduced number intravesical BCG instillations at the standard dosage: A European Association of Urology Research Foundation randomized phase 3 study - NIMBUS - AB 37/10 of the AUO].
authors.affiliation: Geschäftsstelle der AUO, MeckEvidence, Seestr. 11, 17252, Schwarz, Deutschland. auo.presse@meckevidence.de.
authors.forename: H
authors.initials: H
authors.lastname: Rexer
mesh_terms: D000283:Administration, Intravesical; D001500:BCG Vaccine / Q000008:administration & dosage*; D019496:Cancer Vaccines / Q000008:administration & dosage*; D002295:Carcinoma, Transitional Cell / Q000175:diagnosis / Q000473:pathology* / Q000517:prevention & control* / Q000628:therapy; D004334:Drug Administration Schedule; D005060:Europe; D006801:Humans; D009130:Muscle, Smooth / Q000473:pathology; D060787:Neoplasm Grading; D009361:Neoplasm Invasiveness; D012107:Research Design; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000473:pathology* / Q000517:prevention & control*
chemical_list: D001500:BCG Vaccine; D019496:Cancer Vaccines